Skip to main content


U.S. flag
      An official website of the United States government
              Here’s how you know
        Here’s how you knowDot gov**Official websites use .gov**
                 A **.gov** website belongs to an official government organization in the United States.
                  HTTPS**Secure .gov websites use HTTPS**
                 A **lock** (A locked padlock) or **https://** means you’ve safely connected to the .gov website. Share sensitive information only on official, secure websites. 
  Menu Close
          Enter the terms you wish to search for.
    Search
        








  
  
    

  
      

                                      About HHS
    
                        
                              
      
      
      Programs & Services
    
                        
                              
      
      
      Grants & Contracts
    
                        
                              
      
      
      Laws & Regulations Breadcrumb
    Home
                              About
                              Budget
                              HHS FY 2024 Budget in Brief
                              FY 2024 Annual Performance Plan and Report
                              FY 2024 Annual Performance Plan and Report - Strategic Goal 1: Objective 1.2
 Navigate to:
  HHS Family of Agencies
                                            
            
            HHS Agencies & Offices
    
                                                  
                              
            
      
      
      
      Regional Offices
    
                                                  
                                            
            
      
      
      
      Advisory Committees, Task Forces & Initiatives
    
                                                  
                              
            
      
      
      
      Organizational Chart
    
                                    
                              
            
      
      
      
      Leadership
    
                                                  
                                                    
            
      
      
      
      Budget & Performance
                                            
            
            FY 2025 Budget in Brief
    
                                                  
                                            
            
      
      
      
      FY 2025 Annual Performance Plan and Report
    
                                                  
                                            
            
      
      
      
      FY 2024 Contingency Staffing Plan
    
                                                  
                                            
            
      
      
      
      FY 2024 Budget in Brief
    
                                                  
                                            
            
      
      
      
      FY 2024 Annual Performance Plan and Report
    
                                                  
                                            
            
      
      
      
      FY 2023 Contingency Staffing Plan
    
                                                  
                                            
            
      
      
      
      FY 2023 Budget in Brief
    
                                                  
                                            
            
      
      
      
      FY 2023 Annual Performance Plan and Report
    
                                                  
                                            
            
      
      
      
      FY 2022 Contingency Staffing Plan
    
                                                  
                                            
            
      
      
      
      FY 2022 Budget in Brief
    
                                                  
                                            
            
      
      
      
      FY 2022 Annual Performance Plan and Report
    
                                                  
                                            
            
      
      
      
      FY 2021 Contingency Staffing Plan
    
                                                  
                                            
            
      
      
      
      FY 2021 Budget in Brief
    
                                                  
                                            
            
      
      
      
      FY 2021 Annual Performance Plan and Report
    
                                                  
                                            
            
      
      
      
      FY 2020 Contingency Staffing Plan
    
                                                  
                                            
            
      
      
      
      FY 2020 Budget in Brief
    
                                                  
                              
            
      
      
      
      FY 2020 Annual Performance Report
    
                                                  
                                            
            
      
      
      
      FY 2019 Contingency Staffing Plan
    
                                                  
                              
            
      
      
      
      FY 2019 Annual Performance Report
    
                                                  
                                                                  
            
      
      
      
      Strategic Plan FY 2022 - 2026
                                            
            
            Message from the Secretary
    
                                                  
                                            
            
      
      
      
      Introduction: About HHS
    
                                                  
                                            
            
      
      
      
      Overview: Strategic Plan FY 2022 - 2026
    
                                                  
                                            
            
      
      
      
      Strategic Goal 1: Protect and Strengthen Equitable Access to High Quality and Affordable Healthcare
    
                                                  
                                            
            
      
      
      
      Strategic Goal 2: Safeguard and Improve National and Global Health Conditions and Outcomes
    
                                                  
                                            
            
      
      
      
      Strategic Goal 3: Strengthen Social Well-Being, Equity, and Economic Resilience
    
                                                  
                                            
            
      
      
      
      Strategic Goal 4: Restore Trust and Accelerate Advancements in Science and Research for All
    
                                                  
                                            
            
      
      
      
      Strategic Goal 5: Advance Strategic Management to Build Trust, Transparency, and Accountability
    
                                                  
                              
            
      
      
      
      Appendix: Plan Updates
    
                                    
                                            
            
      
      
      
      News
    
                                    
                              
            
      
      
      
      I Am HHS
    
                                    
                              
            
      
      
      
      CareersText resize icon

                    




FY 2024 Annual Performance Plan and Report - Strategic Goal 1: Objective 1.2








  
  
    

  
      



Fiscal Year 2024
Released March, 2023

**Topics on this page:** Objective 1.2: Reduce costs, improve quality of healthcare services, and ensure access to safe medical devices and drugs | Objective 1.2 Table of Related Performance Measures

Objective 1.2: Reduce costs, improve quality of healthcare services, and ensure access to safe medical devices and drugs

HHS supports strategies to reduce costs, improve quality of healthcare services, and ensure access to safe medical devices and drugs for everyone.  HHS develops and implements payment models in partnership with healthcare providers and establishes other incentives to improve quality care while reducing healthcare spending.  HHS implements and assesses approaches to improve healthcare quality, and address disparities in healthcare quality, treatment, and outcomes.  The Department also improves patient safety, strengthens access to safe and effective medical products and devices, and expands approaches to safely exchange information among patients, providers, and payers.

The Office of the Secretary leads this objective.  The following divisions are responsible for implementing programs under this strategic objective: AHRQ, ASPE, CDC, CMS, FDA, HRSA, IHS, NIH, OASH, ONC, and SAMHSA.  In consultation with OMB, HHS has determined that performance toward this objective is progressing.  The narrative below provides a brief summary of progress made and achievements or challenges, as well as plans to improve or maintain performance.

Objective 1.2 Table of Related Performance Measures

*Reduce the average out-of-pocket share of prescription drug costs while in the Medicare Part D Prescription Drug Benefit coverage gap for non-Low Income Subsidy (LIS) Medicare beneficiaries who reach the gap and have no supplemental coverage in the gap (Lead Agency - CMS; Measure ID - MCR23)*
	FY 2017
			FY 2018
			FY 2019
			FY 2020
			FY 2021
			FY 2022
			FY 2023
			FY 2024Target
			43%
			37%
			28%
			25%
			25%
			25%
			25%
			25%Result
			42%
			36.7%
			27%
			25%
			Apr 30, 2023
			Apr 30, 2024
			Apr 30, 2025
			Apr 30, 2025Status
			Target Exceeded
			Target Exceeded
			Target Exceeded
			Target Met
			Pending
			Pending
			Pending
			PendingThe Medicare Prescription Drug Improvement and Modernization Act of 2003 amends Title XVIII of the Social Security Act by adding a Voluntary Prescription Drug Benefit Program (Medicare Part D).  Since its inception, Medicare Part D has significantly increased the number of beneficiaries with comprehensive drug coverage and enhanced access to medicines.

While Medicare Part D offers substantial insurance coverage for prescription drugs, it does not offer complete coverage.  Prior to 2010, a beneficiary was responsible for paying 100 percent of the prescription costs between the initial coverage limit and the out-of-pocket threshold (or catastrophic limit).  Only once the beneficiary reached the catastrophic limit, did Medicare coverage recommence.  This is known as the coverage gap (or “donut hole”).  The Affordable Care Act began closing the coverage gap through a combination of manufacturer discounts and gradually increasing federal subsidies until it closed in 2020.  For CY 2020 and beyond, this means that non-LIS beneficiaries who reach this phase of Medicare Part D coverage will pay no more than 25 percent of costs for all covered Part D drugs. For 2023, beneficiaries reach this phase when total drug costs amount to $4,660 and stay in this phase until they pay $7,400 in qualified out-of-pocket costs. CMS’ tracking of this measure has shown that that in most years non-LIS out-of-pocket costs have decreased beyond the targets required by statute.

The statute which established the Coverage Gap Discount Program gave CMS the authority to authorize exceptions to the requirement that manufacturers have their applicable drugs be covered under a Coverage Gap Discount Program agreement (Section 1860D-43 (C)) in extenuating circumstances.  However, CMS successfully encourages all manufacturers of applicable drug products to participate in the program, which results in the consistent application of discounts for all branded products.  Furthermore, the infrastructure which has been put in place treats manufacturers fairly, which has resulted in manufacturers choosing to stay in the Part D program.  Specifically, it: 1) allows public access to information about which manufacturers are participating in the program, and 2) offers an equitable process for manufacturers to dispute invoiced amounts. This has occurred without any meaningful decreases in manufacturer participation in the Part D market.  As generic utilization in the Part D program has remained static, and very high (over 75 percent since 2012), that is not a strong contributor to the success of this goal.  Rather, CMS’ application and management of the Coverage Gap Discount Program, coupled with the strong incentives for manufacturers to participate in the Part D program, are the primary drivers of this goal’s success.

*Increase the percentage of Medicare healthcare dollars tied to Alternate Payment Models (APMs) incorporating downside risk (Lead Agency - CMS; Measure ID - MCR36)*
	FY 2017
			FY 2018
			FY 2019
			FY 2020
			FY 2021
			FY 2022
			FY 2023
			FY 2024Target
			
			
			Set Baseline
			30%
			40%
			40%
			47 %
			55 %Result
			
			
			20.21%
			24.2%
			24.8
			Dec 15, 2023
			Dec 15, 2024
			Dec 15, 2025Status
			
			
			Baseline
			Target Not Met but Improved
			Target Not Met
			Pending
			Pending
			PendingHHS and CMS, through the Center for Medicare and Medicaid Innovation (CMMI), identifies, tests, evaluates, and expands, as appropriate, innovative payment and service delivery models.  The Medicare Shared Savings Program Accountable Care Organizations (ACOs) also play an integral role in moving Medicare toward value-based payment models and person-centered care, with over 11 million people with Medicare receiving care from a health care provider in a Shared Savings Program ACOs as of January 1, 2022.  These innovative payment and service delivery models can reduce program expenditures for Medicare, Medicaid, and the Children’s Health Insurance Program, while improving or preserving beneficiary health and quality of care.

To further accelerate movement away from paying for volume and towards paying for value and outcomes, CMS lauched a bold new strategy with the goal of achieving equitable outcomes through high quality, affordable, person-centered care.  On October 20, 2021, CMS published a white paper detailing CMS’s vision for the next 10 years (Innovation Strategy Refresh).  In November 2022, CMS published a one-year update on progress made achieving this vision, including measures for success against key objectives (Person-Centered Innovation - An Update on the Implementation of the CMS Innovation Center's Strategy).  As part of this strategic refresh, CMS set a new 10-year Medicare goal and target to have all beneficiaries in a care relationship with accountability for quality and total cost of care by 2030 (see newly developed measure CMMI6).

CMS did not meet its FY 2021 target because of the unprecedented impact of the COVID-19 pandemic, more limited opportunities for enrollment in new CMMI models, and a plateauing of participation in the Medicare Shared Savings Program.

*Review and act on 90 percent of standard original Abbreviated New Drug Application (ANDA) submissions within 10 months of receipt.  (Lead Agency - FDA; Measure ID - 223215)*
	FY 2017
			FY 2018
			FY 2019
			FY 2020
			FY 2021
			FY 2022
			FY 2023
			FY 2024Target
			90%
			90%
			90%
			90%
			90%
			90%
			90%
			90%Result
			96%
			96%
			97%
			95%
			96%
			Feb 29, 2024
			Feb 28, 2025
			Feb 28, 2026Status
			Target Exceeded
			Target Exceeded
			Target Exceeded
			Target Exceeded
			Target Exceeded
			Pending
			Pending
			PendingThe goal of GDUFA III is to build on the successes GDUFA I and II, with a focus on maximizing the efficiency of and utility of each assessment cycle with the intent to reduce the number of assessment cycles for ANDAs and facilitate timely access to quality, affordable, safe, and effective generic medicines.  Certain new enhancements in GDUFA III are specifically designed to foster the development, assessment and approval of ANDAs for complex generic products.  GDUFA III also assures a sound financial foundation to support the vital activities of the Generic Drug Program.  The value of this investment in the Generic Drug Review program is reflected by FDA’s performance on its goals under GDUFA, including the review of standard submissions reflected in this performance measure, as well as FDA’s commitment to meet shorter review goals (8 months) for priority submissions under GDUFA II and GDUFA III.  Despite the unforeseen challenges due to the COVID-19 pandemic, including having to transition to a remote work environment with an increased workload due to the expedited development and review of generic drug submissions for products that could help address the public health emergency, FDA rose to the challenge and maintained its high level of performance in meeting GDUFA’s goals and initiatives.  HHS is confident that the new processes introduced through GDUFA III, and activities taken under FDA’s Drug Competition Action Plan will continue to help reduce assessment cycles, improve approval times, and boost competition, helping to ensure that quality, affordable, safe and effective generic drug products are available to the American public.

*Increase the cumulative number of evidence-based resources and tools available to improve the quality of healthcare and reduce the risk of patient harm.  (Lead Agency - AHRQ; Measure ID - 1.3.41)*
	FY 2017
			FY 2018
			FY 2019
			FY 2020
			FY 2021
			FY 2022
			FY 2023
			FY 2024Target
			177 tools
			187 tools
			200 tools
			225 tools
			250 tools
			275 tools
			300 tools
			325 toolsResult
			180 tools
			191 tools
			204 tools
			225 tools
			250 tools
			275 tools
			N/A
			N/AStatus
			Target Exceeded
			Target Exceeded
			Target Exceeded
			Target Met
			Target Met
			Target Met
			Not Collected
			Not CollectedA major output of the Patient Safety Portfolio is the availability of evidence-based resources and tools that can be utilized by healthcare organizations to improve the care they deliver, and, specifically, patient safety.  An expanding set of evidence-based tools is available as a result of ongoing investments to generate knowledge through research and synthesize and disseminate this new knowledge in the optimal format to facilitate its application.

The Agency continues provide many and a large variety of resources and tools to improve patient safety.  Examples include:

AHRQ Patient Safety Network (AHRQ PSNet) & Web M&M (Morbidity and Mortality Rounds);
	AHRQ Question Builder App;
	AHRQ’s Safety Program for Nursing Homes: On-Time Pressure Ulcer Prevention;
	Common Formats (standardized specifications for reporting patient safety events);
	Guide to Improving Patient Safety in Primary Care Settings by Engaging Patients and Families;
	Healthcare Simulation Dictionary, Second Edition;
	Making Healthcare Safer III Report; Primary Care-Based Efforts To Reduce Potentially Preventable Readmissions;
	*Reducing Diagnostic Errors in Primary Care Pediatrics* (Project RedDE!);
	Re-Engineered Discharge (RED) Toolkit;
	Toolkit To Improve Antibiotic Use in Acute Care Hospitals;
	Understanding Omissions of Care in Nursing Homes.The Patient Safety Portfolio is projecting that the number of evidence-based resources and tools will continue to increase with a projected cumulative number of 275 in FY 2022 and 300 in FY 2023, and 325 in FY 2024.

*Percentage of health centers with at least one site recognized as a patient centered medical home (Lead Agency - HRSA; Measure ID - 1010.11)*
	FY 2017
			FY 2018
			FY 2019
			FY 2020
			FY 2021
			FY 2022
			FY 2023
			FY 2024Target
			65%
			65%
			65%
			70%
			75%
			75%
			75%
			76%Result
			67%
			75%
			76%
			76%
			77%
			Aug 1, 2023
			Dec 15, 2023
			Dec 15, 2024Status
			Target Exceeded
			Target Exceeded
			Target Exceeded
			Target Exceeded
			Target Exceeded
			Pending
			Pending
			PendingHRSA funded health centers improve health outcomes by emphasizing the care management of patients with multiple health care needs and the use of key quality improvement practices, including health information technology.  HRSA’s Health Center Program Patient Centered Medical Home (PCMH) Initiative supports health centers to achieve national PCMH recognition, an advanced model of primary care using a team-based approach to improve quality through coordination of care and patient engagement.  Currently, 77 percent of health centers are recognized by national accrediting organizations as Patient Centered Medical Homes.

PCMH recognition assesses a health center’s approach to patient-centered care and evaluates health centers against national standards for primary care that emphasize care coordination and on-going quality improvement.  PCMH recognition also increases health outcomes, improves health equity, and lowers costs for patients and health centers, and has become a standard of care for HRSA funded health centers.  HRSA set the FY 2024 target based on data trends.

*Increase the number of communities that have access to tele-behavioral health services where access did not exist in the community prior to Telehealth Network Grant Program (TNGP) grant (Lead Agency - HRSA; Measure ID - 6070.01)*
	FY 2017
			FY 2018
			FY 2019
			FY 2020
			FY 2021
			FY 2022
			FY 2023
			FY 2024Target
			--
			--
			N/A
			N/A
			N/A
			N/A
			N/A
			40Result
			--
			--
			17613
			7414
			39
			Dec 31, 2023
			Dec 31, 2024
			Dec 31, 2025Status
			--
			--
			Historical Actual
			Historical Actual
			Pending
			Pending
			Target Not In Place
			Target not in placeHRSA’s Office for the Advancement of Telehealth has several programs that allow grantees to focus entirely, or in part, on expanding access to telebehavioral services in rural and underserved communities.  This measure reflects programs with different focus areas and cohorts.  As such, measure results will vary from year-to-year due to expected turnover in grantee cohorts and focus areas, and targets will need to be evaluated on an ongoing basis.  In addition, recent data represents results from FY 2021 and was collected between September 2021 through August 2022, aligning with the program period.  The targets for FY 2024 have been established based on the current cohorts for TNGP—the Telehealth Network Grant program for emergency services and the Evidence-Based Telehealth Network program for Direct-to-Consumer services—for which tele-behavioral health is not the primary focus.  Past Telehealth Network Grant programs such as the Evidence-based Tele-behavioral Health Network Program (FY 2018 – FY 2020) did allow for grantees to focus solely on telebehavioral health.

*For the Title X program, # of unduplicated clients receiving high-quality services through the program.  (Lead Agency – OASH; Measure ID – 8000.01)*
	FY 2017
			FY 2018
			FY 2019
			FY 2020
			FY 2021
			FY 2022
			FY 2023
			FY 2024Target
			4,259,000
			4,000,000
			3,991,000
			4,018,000
			3,300,000
			3,500,000
			4,250,000
			4,462,500Result
			4,004,246
			3,939,749
			3,095,666
			1,536,743
			1,662,466
			Sep 30, 2023
			Sep 30, 2024
			Sep 30, 2025Status
			Not Met
			Not Met
			Not Met
			Not Met
			Not Met
			Pending
			Pending
			PendingThe Title X Family Planning program is the only federal grant program dedicated solely to providing individuals with comprehensive family planning and related preventive health services.  Enacted in 1970 as part of the Public Health Service Act, the Title X program is designed to provide access to contraceptive services, supplies, and information to all who want and need them.  By law, priority is given to persons from low-income families.

The program’s performance measures focus on increasing access to high-quality care and serving individuals and families from underserved, vulnerable and low-income populations, gauging the extent to which Title X expands the availability of quality healthcare to the public.  Performance measurement guides program strategies, establishes directions for technical assistance, and directs revisions to program policies.  This enables Title X to better address program performance and facilitates methods to increase efficiency in the delivery of preventive healthcare services. 
Of particular importance, Title X service grantees provide high-quality contraceptive counseling and care, recommended chlamydia screening, screening for undiagnosed cervical tissue abnormalities, preconception care and counseling, basic infertility services, pregnancy testing and counseling, adolescent services and related education and counseling.  These services, along with community-based education and outreach, assist individuals and families with pregnancy leading to healthy birth outcomes and prevention of unintended pregnancy.  The target and data collection efforts around unduplicated clients served through the Title X program helps track core performance aligned with Title X’s mission.

The marked decrease in Title X performance between 2021 and 2019 is attributable to two main factors: the 2019 Final Rule and the COVID-19 pandemic.  On March 3, 2019, HHS issued a Final Rule that revised Title X regulations governing several aspects of how Title X-funded projects deliver family planning care.  The implementation of the 2019 Title X Final Rule led to 19 grantees (and their networks) immediately withdrawing from the program; 18 other grantees reported losses to their service networks.  These departures significantly reduced the Title X service network.  While supplemental awards were made to compensate for these departures; the program experienced a net decrease of more than 1,000 service sites.  Additionally, the emergence of the novel coronavirus in 2020 created a public health emergency that affected all aspects of healthcare delivery, which varied in both scope and duration, severely disrupting Title X clinical operations.

In October 2021, the Department amended the Title X Family Planning regulations to restore access to equitable, affordable, client-centered, quality family planning services for more Americans.  Aligned with the new program policies, performance targets have been established to restore the breadth of client access that is central to Title X’s mission.

<<Return to Topics in this Report

Top of page

Goal 1 - Objective 1.3 >>

Endnotes

13 Baseline data includes school-based TNGP and Substance Abuse Treatment (SAT) TNGP which were discontinued after FY 19.  This data and out year data from the Emergency Department (ED) TNGP and Evidence-based (EB) Evidence-based Tele-behavioral Network Program (TNP) programs will be used to identify trending over a three-year period, as the measure is developmental.  Once HRSA analyzes a trend, appropriate targets will be identified.  HRSA expects that with turnover in cohorts and focus areas, the target will need to be evaluated on an ongoing basis.

14 This data represents FY 20 reporting involving the ED TNGP and EB TNP programs which will be used to identify trending over a three-year period, as the measure is developmental.  Once HRSA analyzes a trend, appropriate targets will be identified.  HRSA expects that with turnover in cohorts and focus areas, the target will need to be evaluated on an ongoing basis.

                    
  


Content created by Assistant Secretary for Financial Resources (ASFR) Content last reviewed March 13, 2023 Back to top
    Contact HHS
    
                        
                                            
      
      
      Careers
    
                        
                                            
      
      
      HHS FAQs
    
                        
                                            
      
      
      Nondiscrimination NoticeHHS Archive
    
                        
                                            
      
      
      Accessibility Statement
    
                        
                                            
      
      
      Privacy Policy
    
                        
                                            
      
      
      Viewers & PlayersBudget/Performance
    
                        
                                            
      
      
      Inspector General
    
                        
                                            
      
      
      Web Site Disclaimers
    
                        
                                            
      
      
      EEO/No Fear ActFOIA
    
                        
                                            
      
      
      The White House
    
                        
                                            
      
      
      USA.gov
    
                        
                                            
      
      
      Vulnerability Disclosure Policy
        Sign Up for Email Updates

Receive the latest updates from the Secretary, Blogs, and News Releases.

Sign Up
  HHS Headquarters
          200 Independence Avenue, S.W.
                  Washington, D.C. 20201
                  Toll Free Call Center: 1-877-696-6775​